Dean Investment Associates LLC Lowers Position in Maximus, Inc. (NYSE:MMS)

Dean Investment Associates LLC trimmed its position in shares of Maximus, Inc. (NYSE:MMS) by 34.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,994 shares of the health services provider’s stock after selling 19,095 shares during the quarter. Dean Investment Associates LLC owned approximately 0.06% of Maximus worth $3,446,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Cetera Advisors LLC purchased a new position in Maximus during the first quarter worth approximately $235,000. GAMMA Investing LLC increased its holdings in Maximus by 224.5% in the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock worth $29,000 after acquiring an additional 238 shares in the last quarter. SG Americas Securities LLC raised its position in Maximus by 609.6% during the second quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider’s stock worth $1,224,000 after acquiring an additional 12,266 shares during the period. Wealth Enhancement Advisory Services LLC raised its position in shares of Maximus by 4.5% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider’s stock worth $272,000 after purchasing an additional 136 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in Maximus by 151.6% in the 2nd quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider’s stock valued at $19,980,000 after buying an additional 140,481 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Insider Transactions at Maximus

In related news, insider Michelle F. Link sold 2,208 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the sale, the insider now owns 6,567 shares of the company’s stock, valued at approximately $484,841.61. This represents a 25.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 1.40% of the company’s stock.

Maximus Stock Down 1.5 %

Shares of MMS opened at $72.70 on Friday. Maximus, Inc. has a one year low of $71.75 and a one year high of $93.97. The stock has a market capitalization of $4.38 billion, a price-to-earnings ratio of 14.54 and a beta of 0.73. The stock has a 50 day moving average price of $84.71 and a 200 day moving average price of $87.13. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date was Friday, November 15th. Maximus’s dividend payout ratio (DPR) is 24.00%.

Analyst Ratings Changes

Separately, StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, November 28th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.